We investigated the role of 68Ga-DOTATOC PET/CT in detecting somatostatin receptors (SSTRs) in 19 patients with metastatic adrenocortical carcinoma (ACC) and explored the activity of 90Y/177Lu-DOTATOC Peptide Receptor Radionuclide Therapy (PRRT).
Treatment with 90Y/177Lu DOTATOC in patients with metastatic adrenocortical carcinoma expressing somatostatin receptors
Grisanti, Salvatore;Cosentini, Deborah;Albano, Domenico;Morandi, Alessandra;Laganà, Marta;Bertagna, Francesco;Berruti, Alfredo
2019-01-01
Abstract
We investigated the role of 68Ga-DOTATOC PET/CT in detecting somatostatin receptors (SSTRs) in 19 patients with metastatic adrenocortical carcinoma (ACC) and explored the activity of 90Y/177Lu-DOTATOC Peptide Receptor Radionuclide Therapy (PRRT).File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
